Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS

BACKGROUND: In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for coronavirus disease (COVID-19), was identified as the new pathogen to lead pneumonia in Wuhan, China, which has spread all over the world and developed into a pandemic. Despite the ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Amini, Shahideh, Rezabakhsh, Aysa, Hashemi, Javad, Saghafi, Fatemeh, Azizi, Hossein, Sureda, Antoni, Habtemariam, Solomon, Khayat Kashani, Hamid Reza, Hesari, Zahra, Sahebnasagh, Adeleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338522/
https://www.ncbi.nlm.nih.gov/pubmed/35908022
http://dx.doi.org/10.1186/s40560-022-00625-4

Ejemplares similares

Ejemplares similares